Drug Approval | July 24, 2024
USFDA successfully inspects Carbogen Amcis’s manufacturing sites in Neuland and Aarau
The inspections concluded with no Form 483 observations or significant critical findings
The inspections concluded with no Form 483 observations or significant critical findings
Ephedrine Sulfate injection USP, 50 mg/mL is indicated for the treatment of clinically important hypotension
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
The pooled prevalence of GERD in the Indian population is 15.6 %
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The approved ANDA is therapeutically equivalent to the reference listed drug product
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
The academy has secured partnerships with 15 esteemed hospitals
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Subscribe To Our Newsletter & Stay Updated
